Also trades as: ORNAV.HE (HEL) · $vol 0M · ORINF (OTC) · $vol 0M · ORINY (OTC) · $vol 0M

€80.80 ($90.97)

-0.10 (-0.12%)

Weekly Expected Move ±2.8%

€76 €79 €81 €83 €85

HEL · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 52 · €11.4B mcap · 123M float · 0.147% daily turnover

Revenue

$1.9B +22.5% ▲

5Y CAGR: +11.9%

Gross Profit

$1.2B +28.2% ▲

5Y CAGR: +13.3%

Operating Income

$632M +51.6% ▲

5Y CAGR: +17.7%

Net Income

$500M +51.7% ▲

5Y CAGR: +17.9%

EPS (Diluted)

$3.56 +51.5% ▲

5Y CAGR: +17.8%

EBITDA

$632M +23.0% ▲

5Y CAGR: +13.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.0B	$1.3B	$1.2B	$1.5B	$1.9B
YoY Growth	-3.4%	+28.8%	-11.3%	+29.7%	+22.5%
Cost of Revenue	$448M	$492M	$532M	$596M	$676M
Gross Profit	$594M	$849M	$658M	$946M	$1.2B
Gross Margin	57.0%	63.3%	55.3%	61.4%	64.2%
R&D Expenses	$118M	$136M	$127M	$180M	$210M
SG&A Expenses	$239M	$279M	$300M	$360M	$376M
Operating Expenses	$356M	$413M	$383M	$530M	$581M
Operating Income	$243M	$440M	$275M	$417M	$632M
Operating Margin	23.4%	32.8%	23.1%	27.0%	33.4%
Interest Expense	$1M	$2M	$6M	$8M	$4M
Income Before Tax	$242M	$440M	$272M	$413M	$628M
Tax Expense	$48M	$91M	$55M	$83M	$128M
Net Income	$194M	$350M	$217M	$330M	$500M
Net Margin	18.6%	26.1%	18.2%	21.4%	26.5%
EPS (Diluted)	$1.38	$2.49	$1.54	$2.35	$3.56
EBITDA	$289M	$490M	$328M	$514M	$632M
Shares Outstanding	141M	141M	140M	141M	141M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$471M	$434M	$355M	$416M	$423M	$695M	$418M	$522M
Cost of Revenue	$152M	$167M	$153M	$168M	$169M	$187M	$164M	$182M
Gross Profit	$319M	$267M	$202M	$248M	$254M	$509M	$254M	$340M
Gross Margin	67.8%	61.5%	56.9%	59.6%	60.0%	73.2%	60.8%	65.2%
R&D Expenses	$37M	$62M	$41M	$49M	$50M	$71M	$48M	$62M
SG&A Expenses	$86M	$115M	$84M	$97M	$85M	$111M	$92M	$99M
Operating Expenses	$117M	$175M	$124M	$144M	$134M	$181M	$140M	$161M
Operating Income	$202M	$93M	$78M	$105M	$119M	$328M	$114M	$179M
Operating Margin	42.9%	21.3%	21.9%	25.1%	28.2%	47.2%	27.2%	34.3%
Interest Expense	$600K	$1M	$1M	$1M	$600K	$1M	$1M	$700K
Income Before Tax	$201M	$92M	$77M	$103M	$120M	$327M	$113M	$176M
Tax Expense	$41M	$18M	$16M	$21M	$24M	$67M	$23M	$36M
Net Income	$161M	$73M	$61M	$82M	$96M	$260M	$90M	$140M
Net Margin	34.1%	16.9%	17.3%	19.8%	22.7%	37.5%	21.6%	26.9%
EPS (Diluted)	$1.14	$0.52	$0.44	$0.59	$0.68	$1.85	$0.64	$1.00
EBITDA	$202M	$93M	$92M	$105M	$135M	$328M	$129M	$194M
Shares Outstanding	141M	141M	141M	140M	141M	141M	141M	141M

ORNBV.HE HEL